Clinical trial
Carbon Monoxide to Prevent Lung Inflammation
NCT00094406 · National Institutes of Health Clinical Center (CC), NIH · Completed
Key facts
| NCT number | NCT00094406 |
|---|---|
| Title | Carbon Monoxide to Prevent Lung Inflammation |
| Official title | Effects of Inhaled Carbon Monoxide on Pulmonary Inflammatory Responses Following Endotoxin Instillation |
| Lead sponsor | National Institutes of Health Clinical Center (CC), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Respiratory Distress Syndrome, Adult |
| Intervention type | Drug, Procedure |
| Interventions | Bronchoscopy, Bronchoalveolar lavage, Endotoxin, Carbon Monoxide |
| Enrollment | 35 |
| Start date | Oct 13, 2004 |
| Primary completion | Mar 11, 2010 |
| Completion | Mar 11, 2010 |
| First posted | Oct 18, 2004 |
| Last update posted | Dec 17, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: